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It is well established that the ability to respond to certain antigens is under genetic 
control  and  several  different  types  of control  mechanisms  are  known.  The  genetic 
control of responses to thymus-dependent (TDP  antigens usually affects IgG synthesis 
and two separate types have been observed. The immune response to certain antigens is 
under control of antigen-specific immune response  genes,  which are  localized in  the 
chromosome region determining the major histocompatibility antigens and they exert 
their effect on thymus-derived lymphocytes (1). These genes do not code for the variable 
region of the immunoglobulin receptors on the B cells and a  normal response can be 
induced provided adequate T-cell help is given. A second type of genetic control to TD 
antigens is not antigen specific,  only effects the quantity of the immune response, and is 
not controlled by histocompatibility-linked genes (2). 
The immune response to thymus-independent (TI) antigens can also be under genetic 
control and also in this case two mechanisms, which primarily affect IgM synthesis, can 
be distinguished.  One of these mechanisms concerns the  ability of B  cells to become 
activated by the polyclonal B-cell  activating (PBA) properties inherent to TI antigens. 
In one case (C3H/HeJ), the gene(s) determine(s) the presence of the nonimmunoglobulin 
receptors on B cells for' lipopolysaccharide, which are responsible for B-cell  activation. 
The  genes  are  codominantly expressed  (3,  4)  and  localized on chromosome 4  in  the 
mousey  They  do  not  code  for  the  variable  part  of the  immunoglobulin  receptors. 
Another nonresponding strain to certain TI antigens (CBA/N) lacks PBA  receptors or 
receptor-bearing cells  capable of  reacting to, for example, Ficoll,  and cannot mount an 
immune response to any hapten coupled to this  TI carrier (5).  The gene is localized  on 
the X chromosome.  A  second type of genetic control of  the response to TI antigens con- 
cerns the a-1-3 epitope of dextran (Dx) (6).  The gene(s) determine(s)  low immune  re- 
* Supported  by grants  from  the  Swedish Cancer  Society and  Ministerio  de  Educadion y 
Ciencia Espanol. 
1  Abbreviations  used  in  this paper:  BSS, balanced salt solution; Con A, concanavalin A; Dx, 
dextran; FITC, fluorescein isothiocyanate; HRC, horse erythrocytes; NNP, (4-hydroxy-3,5-dinitro- 
phenyl)acetyl; PBA, polyclonal B-cell activator;  PFC, plaque-forming cells; PHA, phytohemag- 
glutinin;  RBC, erythrocytes;  SRBC, sheep  erythrocytes;  TD,  thymus dependent;  TI,  thymus 
independent. 
2 j. Watson, K. Kelly, M. Largen, and B. A. Taylor. The genetic mapping of a defective LPS 
response gene in C3H/HeJ mice. Manuscript submitted for publication. 
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sponsiveness rather than absence of a  response and at least one of the genes is closely 
linked to allotypes of the heavy chain locus (7), 
We have found that different mouse strains vary in their ability to produce 
antibodies  to  the  a-l-6  epitope  of  Dx  B512,  and  in  certain  strains  a  large 
proportion of mice are total nonresponders (8). Since Dx activates B  cells in the 
absence  of  helper  cells,  such  as  T  cells  and  macrophages  (9),  and  since 
suppressor  T  cells  do  not  affect  this  response  (10),  only  two  fundamental 
mechanisms can account for unresponsiveness, specifically: (a) lack of expres- 
sion of V  genes coding for antibodies against the  ~-1-6 epitope and (b) lack of 
triggering receptors on the B  cells possessing immunoglobulin receptors for the 
epitope. We will show that both types of unresponsiveness can occur in different 
mouse strains. 
Materials and Methods 
Mice of the following strains were used in the present study: A/Sn, A.CA, A.SW,  BALB/c, 
CBA,  CBA/N,  C3H/Tif,  C3H/HeJ,  C57BL, A.TH, A.TL,  4R,  2R,  B10.5M, and certain hybrids 
among these strains. 
Antigens  and  Polyclonal  Activators.  Native  Dx  from  Lactobacillus  mesenteroides  B512 
(average mol wt 5-40  ×  10  ~ daltons), was obtained from ICN Pharmaceuticals Inc., Cleveland, 
Ohio. Other Dx preparations were obtained from Pharmacia, Uppsala, Sweden. 
Native fluorescein isothiocyanate (FITC)-Dx was synthetized from native Dx B512 by reacting 
it with FITC, and was provided  by Dr.  van de Belder, Pharmacia. The final conjugation ratio 
was one molecule of FITC for every 200 glucose residues. 
Lipopolysaccharide  from Escherichia coli 055:B5 was prepared from phenol water extraction 
provided by professor T. Holme (Department of Bacteriology,  Karolinska Institutet). 
Concanavalin A  (ConA)  and  phytohemagglutinin (PHA)  were  obtained from  Pharmacia, 
Uppsala, Sweden,  and Wellcome Reagents Limited, Beckenham, England, respectively. 
Preparation  of Lymphocytes.  Spleens  were  removed  and  teased  with  forceps  in  ice-cold 
balanced salt solution (BSS). After brief sedimentation, the cells in the supernate were washed 
three times in 50 ml of cold BSS and subsequently suspended in culture medium to the desired 
cell  concentration. Cellular viability was  determined in a  hemocytometer after  staining the 
damaged cells with 0.02% trypan blue. 
Assay of  Antibody Synthesis.  Anti-a-l-6  plaque-forming  cells (PFC) were detected by a direct 
PFC  assay with  sheep  erythrocytes  (SRBC) with stearoyl Dx  B512 with a  mol wt  of 70,000 
daltons, as described before by Howard et al. (11). 
Anti-FITC-PFC.  The coupling of FITC to erythrocytes (RBC) has been described before  (12). 
For detection of high, medium, and low aff'mi~y PFC the following concentrations of FITC in 
carbonate bicarbonate buffer pH 9.2 were used: 0.05, (of 0.1) 0.5, and 5 mg/ml. 
Anti-NNP PFC.  RBC were coupled  with  (4-hydroxy-3,5-dinitrophenyl)acetyl (NNP)  as de- 
scribed  by Pasanen and M~ikel~i (13). These cells were  used to detect polyclonal antibody syn- 
thesis. 
Medium.  The  medium used in most of the  experiments was  Eagle's Minimum Essential 
Medium in Earle's  solution, supplemented with  glutamine, non-essential amino acids,  and 
pyruvate, and containing 100 IU of penicillin and 100, ~g of streptomycin/ml, as described  by 
Mishell and Dutton (15). The medium was further buffered by 10 mM of HEPES and the pH 
adjusted to 7.2. All these reagents were obtained from Flow Laboratories, Irvine, Scotland. Most 
experiments were carried out in serum-free medium (14), except where specifically  indicated in 
the figure legends. 
Induction  of Polyclonal Antibody  Synthesis.  Spleen cells were cultured serum-free in 3-cm 
diameter plastic Petri dishes or tubes (NUNC,  Roskilde,  Denmark) with a cell concentration of 
l0  T  cells/ml in 1 ml medium (15) set up in triplicate unless otherwise stated. The cultures were 
incubated at 37°C in plastic boxes filled with a mixture of 10% CO2, 83% N2, and 7% O~. CARMEN "FERNANDEZ  AND  GORAN  MOLLER  1665 
TABLE  I 
Immune Response to the a-1-6 Epitope in 3-4 Mo Old Mice of Different Strains after 
Immunization with 2  p,g Native Dx 5 Days Earlier 
Strain  No.  of mice 
PFC/spleen against 
SRBC  a-l-6* 
CBA  16  90  ±  18  33,340  _+ 4,900 
C57BL  8  330  ±  i00  46,440 _+ 6,900 
A.CA  8  178 _+  52  2,778  ±  1,679 
A  17  105  ±  34  2,786  ±  695 
A.TH  11  11  _+ 9  1,036  _+  770 
A.TL  9  33  _+  15  788  ±  377 
CBA/N  6  2  ±  1  5  _+ 3 
* The PFC response against a-l-6 was tested against SRBC coated with stearoyl Dx (40/~g in 10 
ml) to detect PFC of medium affinity. 
Results 
Strain  Variability  in  the  Response  to  the  ~-1-6  Epitope.  The  immune 
response  to  native Dx  B512  (a-1-6)  was tested in  14  inbred strains and was 
found to be very strain dependent. High responder strains, such as C57BL and 
CBA gave 400-1,000  PFC/106 cells 5 days after immunization with the optimal 
dose  1-2  /~g/mouse.  In contrast,  A,  A.CA,  A.SW,  A.TH,  A.TL,  and  CBA/N 
mice were found to be low or nonresponders to the a-l-6 epitope (8). Over 200 
A.CA  were  tested  and  about  90%  of them  only  gave  0-10  PFC/106  cells, 
which,  at best,  can be classified as an extremely low response.  Other mouse 
strains, such as BALB/c were intermediate responders, exhibiting PFC values 
between the  extremes reported  above.  Occasionally, A.CA mice exhibited a 
high response in terms of the number of PFC.  This response was of very low 
affinity and the causes for this will be the topic of a separate report. A variable 
of importance in determining the level of the response was the age of the mice; 
young mice  of all  strains were  nonresponders.  However,  when comparisons 
were  made  with  mice  of the  same  age  (3-4  mo)  the  strain  differences still 
existed (Table I).  Since the mechanism of low responsiveness was found to be 
different with  strains  A,  A.CA,  A.SW,  A.TH,  and  A.TL as  compared with 
strain CBA/N, they will be dealt with separately. 
Mechanism  of Unresponsiveness  in  Strains  on  A  Background.  The  low 
responsiveness of strains on A background could not be attributed to differences 
in dose requirements, affinity, or kinetics of the immune response, since A.CA 
mice failed to respond to the a-l-6 epitope over a wide range of Dx or FITC Dx 
concentrations and at any time after immunization (Table II). Nonresponsive- 
hess also  affected the immune response  to  Dx  conjugated to the TD  carrier 
horse erythrocytes (HRC) (Table III) even in the presence of  PHA as a polyclonal 
T-cell activator. A.CA mice did not produce anti-a-l-6 antibodies of noncomple- 
ment fixing classes, since sera from A.CA mice did not agglutinate Dx-coated 
RBC. The incorporation of native Dx with Freund's adjuvant did not make the 
mice responsive. 
Low  Responsiveness  is  Not  Due  to  Suppressor  Cells.  The  existence  of 1666  B-CELL  UNRESPONSIVENESS  TO  DEXTRAN 
TABLE  II 
Dose Dependence, Kinetics, and Affinity of the lmmune Response to Native Dx or Dx T 
2000* in High and Low Responder Strains 
Dose 
Strain  Antigen  (~g/mouse)  Day of test 
PFC/10  e against a-l-6 by using 
the following indicators cells 
4  40  400 
CBA  Native Dx  1  4  228  289  268 
10  174  541  289 
100  54  92  72 
1  6  131  339  - 
10  I00  108  133 
100  -  92  60 
1  15  64  183  143 
10  29  208  248 
100 
A.CA  Native Dx  1  4  1  2  1 
10  3  2  6 
100  4  4  8 
1  6  2  4  1 
10  5  2  13 
100  1  2  1 
1  15  1  1  3 
10  1  10  10 
100  1  1  6 
CBA  T 2000  1  4  192  217  129 
10  202  327  199 
100  47  127  107 
1  6  270  237  210 
10  151  239  150 
100  230  -  180 
1  15  113  223  185 
10  105  327  646 
100  17  446  757 
A.CA  T 2000  1  4  5  -  3 
10  0  0  0 
100  6  4  4 
1  6  0  1  0 
10  2  1  0 
100  1  4  2 
1  15  2  28  41 
10  1  0  1 
100  1  28  31 
*Molwt  =  2  ×  10  e. 
,  SRBC coated with 4, 40, or 400 ~g/10 ml of stearoyl Dx during sensitization. 
suppressor  T  cells capable  of specifically  suppressing  an  immune  response  has 
been  reported  in  several  different  systems  (16).  Suppressor  T  cells  were  not 
involved  here,  since  thymectomized,  lethally  irradiated  A.CA  mice  that  had 
been  repopulated  with  syngeneic  anti-theta  serum-treated  bone  marrow  failed 
to respond  to native  Dx  (reference  8  and  not  shown). 
It  still  seemed  possible  that  the  environment  of  A.CA  mice  contained 
suppressor  elements  for the  anti-a-l-6  responding  cells.  To test  this  possibility, CARMEN  FERNANDEZ  AND  GORAN  MOLLER  1667 
TABLE III 
Nonresponder Strains to a-1-6 Cannot Respond to Dx Conjugated to TD RBC 
Strain  Antigens  Mitogen 
PFC/spleen against 
a-l-6*  HRC 
A.CA  Dx 4-HRC  -  0  42,800 
Dx 40-HRC  -  50  48,000 
Dx 400-HRC  -  0  35,600 
CBA x  C57BL  Dx 4-HRC  -  200  180,800 
Dx 40-HRC  -  550  87,600 
Dx 400-HRC  -  4,550  144,000 
A.CA  Dx 4000-HRC  -  0  23,600 
Dx 4000-HRC  PHA i00 ~g  400  40,800 
Dx 4000-HRC  PHA 200/~g  50  33,500 
-  -  0  150 
CBA  x C57BL  Dx 4000-HRC  -  1,800  48,000 
Dx 4000-HRC  PHA  100/~g  12,300  132,800 
Dx 4000-HRC  PHA  200 ~g  6,100  154,000 
--  -  0  275 
* The PFC response was tested against SRBC coated with stearoyl Dx 40-SRBC (40 ~g stearoyl 
Dx per 10 ml).  The background to SRBC was deducted. 
S Four different  conjugates of stearoyl Dx-HRC  were used as antigen. The figures indicate the 
concentration in ~g/10 ml of  stearoyl Dx used for  conjugation. 
A.CA mice were lethally  irradiated  and repopulated with spleen cells from a 
high responder strain  (B10.5M or CBA) and immunized  at the time of repopu- 
lation with native Dx and as a control with HRC. In addition,  spleen cells from 
A.CA  mice  were  transferred  into  lethally  irradiated  high  responder  mice 
(B10.5M or CBA).  The results  (Table IV) showed that  spleen cells from high 
responder  strains  responded  well  to  native  Dx  in  the  A.CA  environment, 
whereas  spleen  cells  from  A.CA  mice  failed  to  respond  even  in  the  high 
responder  strains.  Both groups responded to HRC. Thus,  it appears  unlikely 
that  any  type  of  specific  suppressor  influence  can  account  for  the  lack  of 
immune reactivity against the a-l-6 epitope in A.CA mice. 
Dx is an Efficient Carrier in Dx Low Responsive Mice.  Lack of an immune 
response  to  TI  antigens  could  be  theoretically  caused  by two  fundamental 
mechanisms  (since  suppressive  effects  have  been  excluded)  specifically:  (a) 
lack of PBA receptors  on  the  responding  B  cells,  which  therefore  cannot  be 
activated after binding the antigens or (b) absence of Ig receptors competent to 
passively focus the  antigen  to the responding  B  cells.  In  the  latter  case the 
cells cannot produce antibodies, even if given the correct triggering  signal via 
the PBA receptors. 
The possibility that A.CA mice lack the PBA receptor for Dx was tested in 
two ways. First, it was investigated if Dx could induce polyclonal activation in 
these mice,  as determined  by induction  of antibodies  to unrelated  antigens. 
Second, it was studied if Dx could act as a  carrier for an unrelated hapten in a 
dextran  nonresponder  strain.  Since activation  of B  cells is caused by signals 1668  B-CELL  UNRESPONSIVENESS  TO  DEXTRAN 
TABLE IV 
lmmune Response to a-1-6 and HRC in Irradiated Recipients Reconstituted with 
Spleen Cells from High and Low Responder Strains 
Irradiated recipi- 
Donor 
ents 
PFC/106  spleen cells against 
a-l-6  HRC  NNP 
CBA  CBA  165  320  95 
ACA  CBA  14  84  76 
ACA  ACA  0  62  218 
CBA  ACA  139  268  116 
5M  ACA  1,544  2,500  734 
ACA  ACA  6  340  179 
ACA  5M  2  183  127 
* The  irradiated  recipients  (750 R)  were  given  30  x  106  spleen  cell  i.v.  and  were 
immediately immunized with 1 ~g native Dx together with 0.2 ml of a  10% suspension of 
HRC.  The  PFC  against the  immunizing antigens as  well as  against  SRBC  and  the 
hapten NNP were determined 4 days (CBA) or 5 days (5M) later. 
given to the cells by polyclonal B-cell activating properties of the TI antigen, 
Dx  should  not  be  able  to  work  as  a  carrier  for  unrelated  haptens;  if the 
mechanism of unresponsiveness was lack of PBA receptors for Dx. The results 
were clear  in  both  systems and  showed that  Dx was  as  potent  PBA also in 
A.CA mice.  Thus,  Dx induced polyclonal antibody synthesis in A.CA mice in 
vivo or in vitro as it did in high responder strains  (Figs.  1 and 2). 
When  the  hapten  FITC  was  conjugated  to  Dx  and  the  conjugate  used  to 
immunize A.CA mice as well as high responder strains,  it was found that the 
conjugation of FITC to Dx did not make the A.CA mice respond to a-l-6  (Fig. 
3), in agreement with the findings that conjugation of Dx to HRC did not make 
A.CA  mice competent  to respond  to the  a-l-6  epitope.  However, A.CA mice 
responded strongly to the FITC epitope and were equal in this respect to the a- 
1-6 high responder strains  (Fig.  3).  Thus,  Dx can work as an efficient carrier 
for unrelated haptens, indicating that A.CA mice possess PBA receptors for Dx. 
Polyclonal Activation  of Cells from Low Responder Mice Does Not Induce 
Anti-a-l-6 Antibodies.  The  second  alternative  given  above  (lack of V  gene 
expression against the a-l-6 epitope) can be tested by the use of polyclonal B- 
cell  activators,  since  these  substances  are  competent  to  reveal  the  V  gene 
repertoire of the B cells that are susceptible to activation by a particular PBA. 
This approach has been used successfully to study the presence of immunocom- 
petent cells against the tolerogen in specifically tolerant animals  (17) and even 
to induce autoantibody formation in resting B lymphocytes (18). 
Consequently, polyclonal concentrations of the PBA lipopolysaccharide (LPS) 
were  injected  into  A.CA  mice,  (or  added  to  such  cells  in  culture)  and  as  a 
control also injected into strains that were high responders to the a-l-6 epitope 
(or  added  to  such  cells  in  vitro).  The  groups  were  tested  at  various  time 
intervals  against  different  antigens  (SRBC,  HRC,  NNP,  FITC,  and  a-l-6  of 
high  and  medium  affinity).  The  results  showed that  LPS was  competent  to 
induce  antibody synthesis against  all  epitopes studied  in the  high  responder 
strains, but A.CA and A.TH mice consistently failed to express anti-a-l-6 PFC, CARMEN  FERNANDEZ  AND  GORAN  MOLLER  1669 
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FIG.  1.  induction of polyclonal antibody synthesis by 2 mg native Dx in spleen cells from 
A.CA and A  × C57BL mice. 107 spleen cells were cultivated in serum-free medium in the 
presence or absence of native dx for 2 days and thereafter assayed against F1TC-SRBC by 
using a high epitope density. Bg indicates background in nonimmunized animals. 
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Fro.  2.  Induction of polyclonal antibody synthesis by different concentrations of native 
Dx in vitro by using spleen cells from A.CA (gg) and C57BL  (n) mice. The response was 
tested after 2 days in culture by using the culture system described in Fig. 1 against NNP- 
coated target cells. 
even though  a  PFC  response could easily be detected against  all other antigens 
used  (Fig. 4  and Table V). 
Analogous  experiments  carried  out  in  vivo  with  strains  A  and  CBA  mice 
gave similar results  (Fig. 5). 
CBA/N Mice Lack the Major Part of the B-cell Population Responding to the 
PBA Property of Dx.  A  similar analysis was carried out with CBA/N  mice to 
determine  the  mechanism  of  unresponsiveness  to  a-l-6.  The  results  were 1670  B-CELL  UNRESPONSIVENESS  TO  DEXTRAN 
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immunization i.v.  with  100  /~g/mouse of native  FITC-Dx  B512.  The response was deter- 
mined at day 5 by using the Jerne plaque assay as modified for the detection of PF Cells 
against  a-l-6.  For  detection  of anti-a-l-6  PFC,  SRBC  were  conjugated  with  40  ~g  of 
stearoyl  Dx  in  10  ml  of a  5%  suspension of SRBC.  Anti-FITC  PFC  were  detected  with 
SRBC conjugated with a  solution of 5 mg/ml of FITC. 
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FIG.  4.  Induction of polyclonal antibody synthesis in vivo by injection of 100  ~g of LPS 
i.p. into B10.5M and A.CA mice. The spleens were taken out after 2 and 4 days and tested 
for the number of PFC against a-l-6 and the hapten NNP. The response against a-1-6 was 
undetectable in A.CA mice. 
completely different from those obtained with strains on A background. Thus, 
native  Dx  induced  a  very  small  polyclonal  antibody  response  against  the 
haptens  FITC,  NNP,  or heterologus  RBC  (Fig.  6).  Also the  response  to LPS 
was impaired, but was stronger than the response to Dx. 
When CBA/N mice  (or CBA  ×  DBA F1 males) were immunized with FITC- 
Dx they neither produced PFC nor a-l-6  against FITC.  However, they gave a CARMEN  FERNANDEZ  AND  GORAN  MOLLER  1671 
TABLE  V 
Polyclonally Activating Concentrations of LPS Fail to Induce Anti-a-l-6 PFC in Cells 
from Low Responder Strains In Vitro* 
Treatment of 
Strain 
cultures$ 
PFC/IO  8  cells  against the indicated targets at day 
3  6 
C57BL  a-l-6§  FITCIJ  a-l-6  FITC 
-  0  55  0  100 
LPS  380  2,042  600  5,000 
A.CA  -  10  70  0  67 
LPS  0  1,410  16  1,766 
A.TH  -  30  50  0  17 
LPS  0  880  0  1,700 
* The lymphocytes were cultivated in 2  ml  medium containing 5%  human  A  serum and 5  x 
10-SM 2-mercaptoethanol at a  cell concentration of 3  x  105 cells/ml. 
$ 100/xg/ml of LPS. 
§ Stearoyl Dx at a concentration of 40 ttg/10 ml was used to sensitize SRC as targets in the PFC 
assay. 
II 5 mg/ml of FITC was used to sensitize SRBC as targets in the PFC assay. 
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FIO.  5.  Induction of polyclonal antibody synthesis in viva by the injection of 100 ttg LPS 
into A and CBA mice. Their PFC response against a-l-6 and NNP was followed up to day 
6. A mice (i) responded only to NNP ( .....  ) and not to a-l-6 (  ), whereas CBA mice 
(A) responded to both epitopes. 
definite, although small response against FITC when the hapten was conjugated 
to TD HRC,  indicating that the mice possess V  genes for the FITC epitope 
(Table VI).  Thus, the cause for the unresponsiveness to FITC-Dx in this case 
appears to be the lack of the major part of the B-cell population having PBA 
receptors for Dx, in analogy with the findings that these mice lack triggering 
receptors for other PBA, such as Ficoll. CBA/N mice are analogous in this way 1672  B-CELL  UNRESPONSIVENESS  TO  DEXTRAN 
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Fro.  6.  Polyclonal  activation by LPS and native Dx of spleen cells from CBA/N  x  DBA 
male  and  female  mice.  Half of the  mice  were  untreated,  whereas  the  other  half were 
immunized 5 days earlier with 100 pg of native FITC-Dx and were tested for PFC response 
against  FITC.  Only the immunized  females developed  an immune  response to FITC,  the 
males  were  totally  unresponsive.  The  spleen  cells  were  cultivated  in  RPMI  medium 
containing 5% fetal calf serum and 5  x  10 -~ M 2-mercaptoethanol by using 2  x  106 cells/ml 
and 0.5 ml  per culture  tube.  LPS  (50  ug/ml)  and native  Dx  (4 mg/ml)  were added to the 
indicated cultures.  The cells were harvested on day 3  and tested against NNP-SRBC.  Bg 
indicates background  in nonactivated  cultures. 
TABLE VI 
Immune Response of CBA/N and BALB/c Mice to Native FITC Dx and FITC-HRC* 
Strain 
CBA/NII 
Antigen 
FITC-Dx 
100 ~g 
FITC-HRC 
F]TC-Dx 
100 pg 
FITC-HRC 
BALB/c¶ 
SRBC 
10 
5±5 
35 ±  17 
25 
116 ±  116 
200 ±  57 
HRC 
20 
NT 
3,625 ±  880 
50 
NT 
93,000 ±  30,324 
PFC/spleen against a-I-6¢ 
40  400 
0  0 
10 -+  10  0 
NT  NT 
25  425 
1,933 -+  1,137  1,816 ±  1,238 
NT  NT 
0.2 
120 
45 ±  45 
1,690 ~  630 
175 
30,233 ±  13,700 
35,666 ±  9,700 
FITC§ 
155 ±  63 
2,615 ±  660 
1,250 
46,066 ± 20,500 
50,530 ± 13,300 
* The mice were immunized with 100 ~tg  native FITC-Dx i.v.  and with 0.2 ml of  a 10% suspension of  FITC-HRC labeled  with  0.5  mg/ml of 
FITC. 
* 40 and 400 ~g/10 ml stearoyl  Dx were used to  coat SRBC. 
§  0.2  and 5 mg/ml FITC were used to  coat SRBC. 
II  Four mice/group. 
¶ Three mice/group. 
to the LPS nonresponder C3H/HeJ,  lacking PBA receptors for LPS,  but the 
defect  is  apparently  more  pronounced  and  affects  cells  with  receptors  for 
several  different PBA and the genetic localization of the defect is different (it is 
located on the X chromosome). 
Finally  it  was  tested  if CBA/N  mice  could  produce  anti-c~-l-6  PFC  after 
immunization with the TD conjugate Edistine-Dx (a plant protein conjugated CARMEN  FERNANDEZ  AND  GORAN  MOLLER  1673 
to Dx and provided by Dr. Richter, Pharmacia,  Uppsala, Sweden). However, no 
detectable response was obtained. 
Discussion 
The findings  in this paper illustrate  two fundamentally  different causes of 
immunological unresponsiveness at the B-cell level to the same epitope on Dx. 
Strains on A background were nonresponders because they failed to express V 
genes coding for antibodies against  a-l-6.  In contrast,  strain  CBA/N failed to 
respond to Dx or FITC-Dx, because the ceil population having PBA receptors 
for Dx was severely depleted.  This strain  is therefore analogous to C3H/HeJ 
which cannot respond to LPS or any hapten coupled to LPS, because there is a 
selective loss of PBA receptors for LPS.  CBA/N not only has defective B cells 
capable of responding to the PBA property of Dx, as shown here, but also cells 
responding  to  Ficoll,  pneumococcal polysaccharide  SIII,  and  polyacrylamide. 
It  has  been  claimed  that  this  strain  responds  normally  to  haptenated  LPS, 
indicating  that  it  possesses B  cells  with  PBA receptors  for LPS  (5).  CBA/N 
responded,  although  poorly, to the  PBA property of LPS.  Although  C3H/HeJ 
and CBA]N principally exhibit analogous defects, there are marked differences 
between the  two strains.  The  defect in  C3H/HeJ is  selective for LPS,  and  is 
determined by one gene localized on the fourth chromosome, whereas CBA/N 
lacks receptors or B-cell populations for several different PBA's and the defect is 
X-linked.  It could not be formally established whether CBA/N mice possess V 
genes for a-l-6,  since they did not respond to TD Dx conjugates. 
The fact that A  mice did not respond to Dx,  although  they have cells with 
PBA receptors for Dx, is a new type of immunological unresponsiveness. It is a 
genetically determined  (unpublished observations) inability to respond,  which 
could not be ascribed to lack of helper T cells, presence of suppressor T cells, or 
any suppressive influence of the environment of the mice that did not allow the 
expression of an anti-a-1-6 response. The unresponsive state exhibited stringent 
immunological  specificity, since only the  a-1-6 epitope was affected, whereas 
other  epitopes conjugated  to  Dx induced  normal  immune  responses.  Since  it 
was  not  possible  to  convert  nonresponders  into  responders  by  a  variety  of 
procedures  that  engage  different  helper  cells,  such  as conjugating  Dx to TD 
HRC, injecting it with polyclonal T-cell activators such as PHA and Con A, or 
incorporating  it  into Freund's  adjuvant,  it is unlikely that  the defect can be 
ascribed to lack of helper cells.  Furthermore,  several different PBA's such as 
LPS and PPD, which could activate polyclonal antibody synthesis to all other 
antigenic  determinants  failed  to  do  so  against  a-l-6  in  the  nonresponder 
strains,  whereas expected anti-a-l-6 responses occurred with similarly-treated 
cells from high  responder strains.  It follows from these findings  that  B  cells 
which can be activated by helper T cells, LPS, PPD, and Dx cannot express Ig 
molecules  with  the  a-l-6  variable  region.  Since  these  polyclonal  activators 
probably affect a major part of the B-cell population (LPS alone activates about 
30% of all B cells and these are different from those activated by PPD and Dx) it 
follows that most if not all B  cells do not express the gene responsible for the 
formation of the combining site for a-l-6. 
The lack of detectable anti-a-l-6 antibody-producing cells could be due to two 1674  B-CELL  UNRESPONSIVENESS  TO  DEXTRAN 
main  reasons.  It  is  possible  that  an  a-1-6  clone  or  several  such  clones  are 
present in the nonresponders, but the number of cells in the clones is two small 
to be detected.  Alternatively,  lymphocytes from these  animals  either  lack V 
genes coding for antibodies against a-l-6 or the cells cannot selectively express 
these V genes. Although the possibility that the clone size is too small to allow 
detection  may  be  used  to  explain  the  in  vitro  data  with  PBA,  it  is  highly 
unlikely that it is applicable for the in vivo experiments, since the amplification 
of the response was very pronounced in responder  strains,  which presumably 
have very few clones because of the homogeneity of the affinity of the antibodies 
produced.  Usually the number of PFC against  a-l-6  was 500-2,000 times the 
background 5 days after immunization.  The exponential increase of the immune 
response during  the first 5 days is predominantly  due to division of initially 
activated  precursor  cells  rather  than  to  recruitment  of new precursor  cells. 
Actually it is possible to detect one precursor cell in adoptive transfer experi- 
ments and there is no reason why this would not also be possible against a-l-6 
in vivo with the marked clonal expansion that occurs in high responders. There 
is no reason  why precursor  cells could not multiply in  nonresponder  strains; 
since no suppressor cells have been detected, there is not a need for helper cells, 
and other epitopes coupled to Dx induce a normal anti-hapten  response. 
The 0nly tenable conclusion is that strains  on A  background fail to express 
Ig receptors  and  secrete  antibodies  directed  against  the  c~-1-6 epitope  in the 
majority of the individuals.  The mechanism by which a few individuals secrete 
antibodies against this epitope will be discussed below. It seems highly unlikely 
that some control mechanism would exist that selectively prevents the synthesis 
from messenger RNA of antibodies directed only against one particular epitope. 
It is more plausible that the defect is at the DNA level. Two mechanisms could 
account for the genetically determined state of unresponsiveness to Dx at the 
DNA level, namely lack of V genes coding for antibodies against a-l-6 or lack 
of V-C gene  translocation  for this  particular  specificity.  Neither  alternative 
has precedence,  but both are possible.  The  possibility that  different V  genes 
would  translocate  at  different  rates  (or  not  at  all)  is  compatible  with  our 
findings  (unpublished  observations)  that  high  responder  strains  to the  a-1-6 
epitope do not express this antibody during  the 1st mo of life, even when the 
cells  are  polyclonally activated,  for example,  by LPS,  whereas  they express 
antibodies of all other specificities.  This  suggests that  the V-C translocation 
can  occur at  different  times  for  different  V  genes.  It  is  possible that  the  V 
gene coding for anti-a-l-6  actually exists in strains on A background, but that 
it never,  or rarely,  translocates  to a  C  gene.  Conclusive experiments on this 
point require experiments at the DNA level. 
A  certain  proportion  of mice  on strain  A  background  produced  antibodies 
against  a-l-6,  in most cases to a  very small degree.  Usually the PFC differed 
markedly from those in high responder strains, because they were unclear and 
of very low affinity,  since they were detected easily and in high numbers only 
with target cells coated with a  high epitope density. This is in contrast to the 
PFC  obtained  in  high  responder  strains,  which  were of uniform  affinity;  no 
difference  in  number  or  clarity  was  observed  with  target  cells  of different 
epitope density,  suggesting  a  mono-  or pauciclonal  response.  Mice lacking  a CARMEN  FERNANDEZ  AND  GORAN  MOLLER  1675 
particular  V  gene may occasionally make use of another  V  gene,  which may 
have mutated so as to cause the appearance of an antibody crossreacting with 
the epitope for which a  V gene is lacking.  This may very well be the case with 
the small proportion of animals responding to the a-l-6 epitope in strains of A 
background.  Occasionally, the PFC of low responder mice were undistinguish- 
able from those of high responder strains.  This could be caused by a successful 
V-C translocation also in strains on A background, provided that a lack of this 
type of translocation is the mechanisms for unresponsiveness. 
The  possibility  that  mice  on  A  background  do  not  express  Ig  receptors, 
because they have been tolerized by exposure to bacterial products containing 
a-l-6 is highly unlikely. Thus, we have previously shown (19) that immunolog- 
ical tolerance to an epitope on Dx only affects a subpopulation of B cells with Ig 
receptors for the epitope.  This  subpopulation is characterized  by having PBA 
receptors for Dx as well as Ig receptors for the epitope. Thus,  tolerance is not 
due  to  clonal  deletion  and  many  specific  B  cells  in  tolerant  mice  can  be 
activated  by different  PBA's to  synthesize  antibodies  against  the  tolerogen. 
Similarly,  we have  shown  (unpublished  observations) that  lymphocytes from 
Dx tolerant after treatment with dextranase can be activated by LPS, but not 
with  Dx  to  the  synthesis  of antibodies  against  the  tolerogen.  Finally,  Dx- 
tolerant mice injected with dextranase can make specific high affinity antibod- 
ies to Dx after immunization  with dextran  coupled to a  variety of TD and TI 
carriers,  but  never  after  immunization  with  Dx  alone.  These  findings  show 
that  only  the  B  cells  which  have  both  Ig  and  PBA  receptors  for  Dx  are 
irreversibly  tolerized,  other  specific  B  cells  remain  unaffected  and  can  be 
activated by immunization  with dx coupled to other carriers.  Since we have 
performed analogous experiments here (Tables III and V) and failed to activate 
anti-Dx  antibodies in  A.CA mice,  the possibility that  A.CA  mice are  nonre- 
sponders because they are tolerant can be ruled out. 
A detailed study on the genetics of unresponsiveness to the a-l-6 epitope will 
be given elsewhere, but it is clear that the genes responsible are not linked to 
H-2 region since A, A.CA, A.SW, A.TL, and A.TH all have differences in differ- 
ent parts  of the 1-1-2 complex including  the I  region  and they are  all  low re- 
sponders.  These  strains  have  the  same genetic  background  except  H-2  indi- 
cating that the genes are not present in the major histocompatibility complex. 
Summary 
The immune response of mice to the a-l-6 epitope of dextran  (Dx) B512 was 
found to be under genetic control. The congenic mouse strains A, A.CA, A.SW, 
A.TH,  and  A.TL  exhibited  a  specific defect in  their  response  to  a-l-6.  Also 
strain  CBA/N was unresponsive to a-1-6, but the mechanism of unresponsive- 
ness was found to be different. 
Unresponsiveness to  a-l-6  in congenic A  strains  was not due to suppressor 
cells.  Although  these  strains  failed  to  respond  to  the  a-l-6  epitope,  they 
responded strongly to the hapten Fluorescein isothiocyanate (FITC) conjugated 
to  Dx,  indicating  that  the  Dx  can  function  as  an  efficient  carrier  in  these 
strains.  Dx was a  potent polyclonal B-cell activator  in  congenic A  strains  as 
well  as  in  high  responder  strains.  Polyclonally-activating  concentrations  of 1676  B-CELL  UNRESPONSIVENESS  TO  DEXTRAN 
lipopolysaccharide  (LPS) failed to induce the synthesis of anti-a-l-6 antibodies 
in congenic A strains, although antibodies of all other specificities studied were 
produced.  However,  in  high  responder  strains,  LPS  induced  the  synthesis  of 
anti-a-l-6 antibodies.  It was concluded  that congenic A  strains do not express 
V  genes coding for antibodies against a-l-6. 
In  contrast,  strain  CBA/N  failed  to  respond  to  both  the  a-l-6  and  FITC 
epitope on Dx, whereas they could respond to FITC conjugated to horse erythro- 
cytes. Dx induced a  very small, if any, polyclonal antibody response in B  cells 
from CBA/N mice or male CBA/N x  DBA hybrids, whereas Dx was a very potent 
polyclonal B-cell activator in female hybrids.  It is concluded that CBA/N mice 
are nonresponders to Dx or haptenated Dx, because the cell population that can 
respond to the polyclonal B-cell activating properties of Dx is severely depleted. 
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